Package 16729-243-31

{"route": ["INTRAVENOUS"], "spl_id": "46296320-1014-df71-e063-6294a90ac862", "openfda": {"nui": ["N0000175609", "N0000000176"], "upc": ["0316729243308"], "unii": ["7M7YKX2N15"], "rxcui": ["637549"], "spl_set_id": ["7636bc1e-77b6-46ad-9df0-c8bb1c5e503f"], "pharm_class_epc": ["Topoisomerase Inhibitor [EPC]"], "pharm_class_moa": ["Topoisomerase Inhibitors [MoA]"], "manufacturer_name": ["Accord Healthcare Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 CARTON (16729-243-31)  / 4 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "16729-243-31", "marketing_start_date": "20200708"}], "brand_name": "Topotecan", "product_id": "16729-243_46296320-1014-df71-e063-6294a90ac862", "dosage_form": "INJECTION", "pharm_class": ["Topoisomerase Inhibitor [EPC]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "16729-243", "generic_name": "Topotecan", "labeler_name": "Accord Healthcare Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topotecan", "active_ingredients": [{"name": "TOPOTECAN", "strength": "1 mg/mL"}], "application_number": "ANDA204406", "marketing_category": "ANDA", "marketing_start_date": "20200708", "listing_expiration_date": "20261231"}